PTGX
Protagonist Therapeutics Inc.
Company Overview
| Mkt Cap | $4.88B | Price | $78.62 |
| Volume | 725.89K | Change | +0.99% |
| P/E Ratio | 17.7 | Open | $77.53 |
| Revenue | $434.4M | Prev Close | $77.85 |
| Net Income | $275.2M | 52W Range | $33.31 - $93.25 |
| Div Yield | N/A | Target | $76.46 |
| Overall | 63 | Value | 55 |
| Quality | 68 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyProtagonist Therapeutics Inc. (PTGX) is a leading Healthcare company in the Biotechnology industry, currently trading at $78.62 with a market capitalization of $4.88 billion. The stock is positioned in the upper portion of its trading range, demonstrating solid quality metrics with a MarketXLS quality score of 68.
Today's trading session shows PTGX with a volume of 726K shares. The stock opened down 0.41% from yesterday's close of $77.85. Current analyst estimates project earnings of $-1.86 per share for this year, with next year targeting $0.06.
PTGX demonstrates positive technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for PTGX include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest limited upside of -2.7%. The stock shows neutral valuation indicators based on valuation analysis.
Analysis generated on November 3, 2025 at 08:37 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PTGX | $78.62 | +1.0% | 725.89K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Protagonist Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW